Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
version: 43; Last updated: 2026-08-29 12:20:39+0000
Profiles: ComparativeEvidenceReportExpanded, PICOTaggedComposition
Artifact Description:
This is an example of a Comparative Evidence Report Expanded (with baseline characteristics and participant flow) describing the QUARTET USA Randomized Controlled Trial for the EBM on FHIR Implementation Guide.
ArtifactPublicationStatus: Active
url: https://fevir.net/resources/Composition/372776
identifier: FEvIR Object Identifier/372776
status: Final
type: Comparative Evidence Report
date: 2026-08-29 12:20:39+0000
author: Joanne Dehnbostel
title: Comparative Evidence Report Expanded for QUARTET USA Trial
classification
type: Population
Classifiers
Concept Hypertensive disorder
classification
type: Intervention
Classifiers
Concept candesartan bisoprolol amlodipine indapamide
classification
type: Comparator
Classifiers
Concept candesartan
classification
type: Outcome Measure
Classifiers
Concept Good hypertension control Blood pressure systolic and diastolic
custodian: Computable Publishing LLC
| Type | Target[x] |
| Cite As | Comparative Evidence Report Expanded for QUARTET USA Trial [Database Entry: FHIR Composition Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 372776. Revised 2026-08-29. Available at: https://fevir.net/resources/Composition/372776. Computable resource at: https://fevir.net/resources/Composition/372776#json. |